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radiotherapy are planned, including specialized tools for 
quick visual evaluation and manual corrections. 
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Purpose/Objective: 4DCT allows visualisation of tumour and 
organs at risk motion over the whole breathing cycle. This 
enables the creation of an internal target volume and 
individualised planning margins. At UCLH previous practice 
for node positive lung cancer was to perform a helical scan 
plus IV contrast, to delineate the nodal areas. A region of 
interest 4DCT was then acquired for tumour motion. It was 
deemed not possible to maintain contrast enhancement 
through the entire total lung 4DCT. However, after 
discussions with the UCLH imaging department, from 
November 2013, a new practice to administer contrast whilst 
obtaining a total lung 4DCT scan was instigated. A 
retrospective audit was conducted to compare enhancement 
of the contrast in both practices and its acceptability for 
radiotherapy planning. 
Materials and Methods: The radiotherapy scans for 40 lung 
cancer patients were used to evaluate the enhancement of 
contrast throughout vascular structures. Retrospective 
evaluation of helical CT plus contrast followed by a regional 
4DCT of 20 patients and prospective evaluation of total lung 
4DCT plus contrast in 20 patients was performed. All patients 
received 100ml Omnipaque 350 mgI/mL intravenously in the 
arm. During the helical scan, a flow rate of 2-3ml/s and a 
time delay of 35 seconds were used. During the total lung 
4DCT scans, a flow rate of 1ml/s and a time delay of 45 
seconds were used. For each scan, on the axial slices an area 
profile of 9 x 9mm was created to determine the mean 
Hounsfield unit (HU) and standard deviation (SD) of the 
following structures: ascending aorta, right atrium, left 
ventricle, right ventricle and descending aorta at the inferior 
aspect of both the heart and lungs. This method is consistent 
with Cademartiri et al (2006). 
Results: The sample consisted of 29 males and 11 females 
with diagnoses of 11 NSCLC, 6 SCLC, 13 SCC, 8 
adenocarcinomas and 2 presumed lung cancers. 
 
 
The population mean HU and SD for the total lung 4DCT were 
lower compared to the helical scan (155HU ± 11) vs (233HU ± 
16). However, all total lung 4DCT plus contrast scans were 
clinically acceptable for radiotherapy purposes and none 
have been rejected due to limited contrast enhancement 
since the change of practice. 
Conclusions: The level of contrast enhancement within the 
total lung 4DCT scans is clinically acceptable for the purpose 
of delineation of thoracic target volumes and organs. A total 
lung 4DCT with contrast results in a lower CT dose to the 
patient than a helical scan with contrast followed by a 
regional 4DCT. This streamlined process reduces the scan 
time for the patient in the radiotherapy position which 
increases patient compliance. This new practice results in a 
single dataset which reduces the inherent error of co-
registering multiple datasets and reduces the risk of 
delineation on the incorrect dataset.  
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Purpose/Objective: Tracking, gating and free-breathing (FB) 
systems are three stereotactic body radiation therapy 
techniques (SBRT) which can be used for lung treatments. 
The purpose of this study is to look deeper in the advantages 
from one technique to the other by a dosimetric parameters 
comparison. 
Materials and Methods: Ten patients, previously treated 
using linac-based SBRT, were selected for this analysis. 4DCT 
data were acquired for each patient and sorted into 10 
phases of breathing cycle such as 0% and 50% phases defined 
respectively inhalation and exhalation maximum. GTVph, 
PTVph (=GTVph+3mm) and healthy irradiated lung were 
contoured on each phase. The prescribed dose was 60Gy in 4 
fractions. For tracking technique, 3D conformal SBRT with 9 
fields were planned for every phase and were summed. 
Tracking plans were normalized such as 99% dose covered 99% 
of PTVph and respected dose constraints of ROSEL study.  
Gating technique was analyzed with 3 exhalation phases (40-
50 and 60% phases). For free-breathing technique, ITVFB was 
created from a sum of all GTVph and 3mm margin on ITVFB 
defined a PTVFB. PTVFB was reported on each respiratory 
phase images and dose distributions were calculated. The 
dose normalization and dose constraints were the same as for 
tracking technique. Finally, 10 plans were summed. This 
method allowed knowing the dose really received by the GTV 
(from all GTVph) during a free-breathing irradiation.  
The 3 modalities were evaluated using dose-volume 
histograms of each GTVph and PTVph, homogeneity index 
(HI=(Dmax-Dmin)/Dmean) and the doses to healthy irradiated lung 
(Dmean and V20Gy). 
Results: Despite similar maximum doses, free-breathing 
system improved the target coverage by increasing Dmin and 
Dmean. Target coverage was slightly more homogeneous with 
this technique too. On the other hand, the healthy irradiated 
lung is better protected with tracking system even if dose 
constraints were respected in the 3 cases (V20Gy<10%). 




Conclusions: Tracking, gating and free-breathing techniques 
provide plans with good target coverage and healthy lung 
protection. While an irradiation with free-breathing increases 
doses to GTV and PTV, an irradiation with tracking system 
spares better the healthy lung but can dramatically increase 
the treatment complexity.  
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Purpose/Objective: If electron, chosen for superficial 
oncotherapy, was applied with bolus, it could work as an 
important factor to a therapy result by showing a drastic 
change in surface dose. Hence the calculation value and the 
actual measurement value of surface dose of Treatment 
Planning System (TPS) according to four variables influencing 
surface dose when using bolus on an electron therapy were 
compared and analyzed in this paper. 
Materials and Methods: Four variables which frequently 
occur during the actual therapies ( A: bolus thickness - 3, 5, 
10 mm, B: field size - 6x6, 10x10, 15x15 cm2, C: energy - 6, 
9, 12 MeV, D: gantry angle - 0 °, 15 ° ) were set to compare 
the actual measurement value with TPS(Pinnacle 9.2, philips, 
USA). A computed tomography (lightspeed ultra 16, General 
Electric, USA) was performed using 16 cm-thick solid water 
phantom without bolus and total 54 beams where A, B, C, 
and D were combined after creating 3, 5 and 10 mm bolus on 
TPS were planned for a therapy. At this moment SSD 100 cm, 
300 MU was investigated and measured twice repeatedly by 
placing it on iso-center by using EBT3 film(International 
Specialty Products, NJ, USA) to compare and analyze the 
actual measurement value and TPS. Measured film was 
analyzed with each average value and standard deviation 
value using digital flat bed scanner (Expression 10000XL, 
EPSON, USA) and dose density analyzing system (Complete 
Version 6.1, RIT, USA). 
Results: For the values according to the thickness of bolus, 
the actual measured values for 3, 5 and 10 mm were 
101.41%, 99.58% and 101.28% higher respectively than the 
calculation values of TPS and the standard deviations were 
0.0219, 0.0115 and 0.0190 respectively. The actual values 
according to the field size were 6x6, 10x10 and 15x15 cm2 
which were 99.63%, 101.40% and 101.24% higher respectively 
than the calculation values and the standard deviations were 
0.0138, 0.0176 and 0.0220. The values according to energy 
were 6, 9, and 12 MeV which were 99.72%, 100.60% and 
101.96% higher respectively and the standard deviations were 
0.0200, 0.0160 and 0.0164. The actual measurement value 
according to beam angle were measured 100.45% and 
101.07% higher at 0 ° and 15 ° respectively and standard 
deviations were 0.0199 and 0.0190 so they were measured 
0.62% higher at 15 ° than 0 °. 
Conclusions: As a result of analyzing the calculation value of 
TPS and measurement value according to the used variables 
in this paper, the values calculated with TPS on 5 mm bolus, 
6x6 cm2 field size and low-energy electron at 0 ° gantry 
angle were closer to the measured values, however, it 
showed a modest difference within the error bound of 
maximum 2%. If it was beyond the bounds of variables 
selected in this paper using electron and bolus 
simultaneously, the actual measurement value could differ 
from TPS according to each variable, therefore QA for the 
accurate surface dose would have to be performed. 
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Purpose/Objective: The volume of gas in the upper 
abdominal region in patients treated for distal esophageal 
cancer can change during the course of radiotherapy and this 
can influence daily dosimetry. Recently we have observed 
individual cases in which systematic local dose differences up 
to 10% occurred for which replanning was needed. More 
knowledge on the behaviour of abdominal gas is essential for 
creating a protocol on how to deal with systematic and 
random changes in the amount of gas. The aim of this study 
was to quantify changes in the amount of gas in the area of 
the planning target volume (PTV) over the course of 
radiotherapy. 
Materials and Methods: This study was performed on two 
populations. Group A consisted of 19 randomly selected distal 
esophageal cancer patients and group B consisted of 7 distal 
esophageal cancer patients already showing a large initial 
amount of gas on the planning CT-scan. Patients received 
preoperative or definitive chemoradiotherapy. Radiotherapy 
consisted of 41.4Gy and 50.4Gy, respectively, in 1.8Gy dose 
per fraction. Chemotherapy was administered weekly and 
consisted of carboplatin and paclitaxel. The amount of gas in 
the upper abdomen was determined on weekly cone beam CT 
(CBCT) scans at the level of the PTV. Voxels with CBCT units 
below -525 were considered to be gas, and units above -525 
were considered abdominal tissue. Lung was not considered 
as gas volume, therefore all slices were visually checked and 
manually edited if necessary. This procedure was performed 
for every patient on 4 CBCT-scans from each week of 
treatment. The initial CT-scan was not used in this study, to 
get a consistent comparison, independent of possible grey 
value differences between CT and CBCT. Averages and 
standard deviations (SD) were calculated for both populations 
for each week of the treatment. Statistical tests were 
performed to test for significance in the differences in the 
amount of gas between the different weeks of treatment. 
Results: Figure 1 shows the results of the weekly gas volume 
measurements of individual patients from group A. Averages 
of both groups are presented in table 1. No significant 
differences were found between the subsequent weeks of 
treatment in either of the investigated populations, although 
